TD Cowen began coverage of Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy rating, citing the company's strong position in ...

TD Cowen adjusted its outlook on McDonald's Corporation (NYSE:MCD) shares, raising the price target from $300.00 to $305.00.

In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Axis Capital (AXS – Research Report), with a price target ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Amicus (FOLD – Research Report), with a price target of $20.00.

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

News of a significant price-target boost from an analyst tracking GDS Holdings ( GDS 7.20%) was the main catalyst behind the ...

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

However, 10 companies defied a broader market optimism, mostly due to a series of stock rating downgrades from investment ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

The transportation sector will be impacted by Trump's new tariff regime. Parcel consolidators and freight forwarders - like ...